Health and Fitness, is important to living a healthy life. Learn the newest research from our Press Releases today.
BLOOMFIELD HILLS, Mich., Sept. 15, 2023 /PRNewswire/ — Prominently featured in The Inner Circle, Edsa Negussie is acknowledged as a Top Pinnacle Professional for her contributions to the field of Radiology. Dr. Negussie pursued higher education while in Ethiopia at Addis Ababa University…
The Alarming Rise
Over the past decade, Florida has seen a concerning uptick in medical malpractice claims. Some attribute this to the state’s growing population, while others point to systemic issues within the healthcare sector. Factors such as outdated medical equipment, lack of continuous training for medical professionals, and administrative pressures have all been cited as contributing to the problem.
Dr. Lorraine Stevens, a healthcare analyst, commented, “The surge isn’t just about numbers. It’s about a system that, in places, is failing its patients. We need comprehensive reform, from medical school curriculums to hospital administration.”
David Morales: A Symbol of a Larger Issue
David Morales’s ordeal began with a routine surgical procedure. However, due to alleged oversights, he faced life-threatening complications. The subsequent legal battle, led by renowned medical malpractice lawyer Percy Martinez, shone a spotlight on the vulnerabilities patients face, even in reputed medical institutions.
Morales’s family, while grateful for the legal victory, emphasized the non-monetary implications. “No amount can bring back the life we once knew,” remarked a family member. “But this case can be a catalyst for change.”
The Human Cost of Malpractice
Beyond the staggering financial settlements and legal battles, the true cost of medical malpractice is human. Every case represents a life disrupted, a family grieving, or dreams shattered. For David Morales and countless others, the physical and emotional scars run deep.
Jane Rodriguez, a therapist specializing in trauma, notes, “The psychological impact of medical negligence is profound. Patients often grapple with trust issues, anxiety, and a sense of betrayal by the very professionals they turned to for healing.”
Stories abound of patients facing long-term health issues, requiring additional surgeries, or undergoing extensive therapy due to medical oversights. The ripple effect touches families too, as they adjust to new realities and provide support to their loved ones.
A Call for Collective Action
While individual cases like that of Morales make headlines, the solution to the medical malpractice crisis in Florida requires collective action. Healthcare professionals, legal experts, patient advocacy groups, and policymakers must come together to address the root causes.
Initiatives such as community awareness programs, patient education seminars, and collaborative workshops for medical professionals can pave the way for a safer healthcare environment. Additionally, fostering open communication between patients and doctors can prevent misunderstandings and ensure that concerns are addressed promptly.
Dr. Alan Foster, a surgeon with over three decades of experience, emphasizes, “It’s a shared responsibility. While we, as medical professionals, must continuously upgrade our skills and adhere to best practices, patients too can play a role by being informed and proactive about their health.”
The Road Ahead
The Morales case has ignited discussions on medical malpractice reforms in Florida. Proposed measures include:
As Florida confronts this challenge, the hope is that the state’s healthcare system can transform, ensuring that every patient’s safety and well-being are prioritized.
Percy Martinez is the attorney at Percy Martinez – Medical Malpractice lawyers, 2655 S Le Jeune Rd #504, Miami, FL 33134 Phone: (305) 529-0001, specializing in healthcare and legal intricacies. For insights and stories, reach out to him at p[email protected]
Media Contact
Percy Martinez, Percy Martinez – Medical Malpractice Lawyers, 1 (305) 529-0001, [email protected], https://percymartinezlaw.com
Percy Martinez, Percy Martinez – Medical Malpractice Lawyers, 1 (305)529-0001, [email protected], https://percymartinezlaw.com
SOURCE Percy Martinez – Medical Malpractice Lawyers
“We are thrilled that Dr. Rahadwa is joining the Shearwater team while the severity of the global nursing shortage continues,” said Tom Kendrot, chief executive officer, Shearwater Health. “Dr. Rahadwa’s significant experience and leadership within the provider market will be a valuable addition to the Shearwater team, allowing us to help reshape how nurses and clinicians are deployed within the healthcare space to achieve productivity and efficiency.”
Nashville-based Shearwater Health has trained and augmented care teams with remote and onsite clinicians since 1973, reducing the strain on the healthcare system. With a global workforce of more than 4,000 expertly trained, clinical resources supported by innovative technology and Six Sigma process excellence, Shearwater Health offers both remote and onsite clinical expertise that can be deployed rapidly and securely. The organization recruits and trains nurses in skills such as utilization management, care management, patient care, and revenue cycle and supports their careers through education including the US Nursing Licensure Exam.
Dr. Rahadwa echoed this sentiment, expressing her gratitude and excitement to join the Shearwater family. “I am truly honored and delighted to join Shearwater Health, a company renowned for its dedication to quality and innovation in the healthcare space. I look forward to working closely with Tom and other visionary leaders along with the amazing team towards improving healthcare outcomes, further propelling the organization to new heights!”
As Shearwater Health continues to carve out its place as a leader in the healthcare industry, the inclusion of Dr. Rahadwa is a testament to the company’s commitment to attracting the best talent to serve its mission.
The team at Shearwater Health warmly welcomes Dr. Rahadwa and is eager to witness the transformative contributions she is bound to make in her new role.
About Shearwater Health
Shearwater Health provides teams of remote and onsite clinicians that expand the size and impact of clinical teams so that clients can focus on internal teams practicing at the peak of their license. From bedside to back-office, there are over 4,000 Shearwater clinicians solving medical and administrative problems every hour of every day all over the world. Shearwater combines clinical expertise with Six Sigma process excellence and RPA technology to improve healthcare outcomes. For more information, please visit https://shearwaterhealth.com/ or on Linked In
Media Contact
Heather Rivenburg, Punching Nun Group, 1 703-216-3893, [email protected], Punching Nun Group
SOURCE Shearwater Health
Prevent Blindness is also debuting a new episode in the online Focus on Eye Health Expert Series, “Uveitis and Inflammatory Eye Diseases.” Jeff Todd, president and CEO of Prevent Blindness, interviews Steven Yeh, MD, Professor and Stanley Truhlsen Jr. Chair of Ophthalmology, Truhlsen Eye Institute, University of Nebraska Medical Center. Dr. Yeh is also a volunteer on the Prevent Blindness Scientific Committee.
The uvea is a layer of the eye made up of three parts from the front to the back of the eye that helps provide nutrients to the eye. Uveitis is a term used to describe a group of inflammatory diseases or inflammation of the eye, which can be serious and lead to permanent vision loss. Uveitis causes about 30,000 new cases of blindness each year in the United States.
Signs and symptoms of uveitis include:
In addition to uveitis, there are many other types of IED. To help explain, Prevent Blindness offers the “Inflammatory Eye Disease” episode of the Focus on Eye Health Expert Series. This episode features Ann-Marie Lobo-Chan, MD, MS, of the Illinois Eye and Ear Infirmary, Associate Professor of Ophthalmology, Co-Director, Uveitis Service, University of Illinois College of Medicine, Department of Ophthalmology, and patient Addison Schwaller, Emergency Medicine Physician Assistant at Logansport Memorial Hospital in Logansport, Ind.
“Although ‘Inflammatory Eye Disease’ may not be a term that most people are familiar with, it is a condition that can have severe impact on vision if left untreated,” said Todd. “We encourage people to educate themselves on the various types of IEDs and whether they are at risk for, or have developed them already, to help prevent unnecessary vision loss.”
For more information on inflammatory eye disease, please visit https://preventblindness.org/inflammatory-eye-disease.
For a listing of vision care financial assistance programs in English or Spanish, visit https://preventblindness.org/vision-care-financial-assistance-information.
About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, X, Instagram, Threads, LinkedIn and YouTube.
Media Contact
Sarah Hecker, Prevent Blindness, 312.363.6035, [email protected], PreventBlindness.org
SOURCE Prevent Blindness
Recent Studies Highlight Menopause-Induced Microbiota Changes and Their Health Consequences
PHILADELPHIA, Sept. 14, 2023 /PRNewswire-PRWeb/ — FemmePharma, a leading innovator in women’s wellness products, today announced the launch of their latest breakthrough product, Mia Vita® Women’s Probiotic, a vegetarian and gluten-free oral supplement to support a healthy gut and vaginal microbiome.
Recent studies from the National Library of Medicine have shown that during menopause the gut, vaginal, and urinary microbiota are altered due to drastic hormone changes which may cause several physical changes and subsequent health consequences. This can lead to an imbalance called dysbiosis.
This shift in gut microbiota may contribute to symptoms commonly associated with menopause, such as weight gain, mood changes, and metabolic disruptions. Maintaining a balanced gut microbiome through dietary and lifestyle interventions can play a crucial role in supporting women’s overall health and well-being during this transitional phase.
Backed by extensive research and the expertise of leading experts, Mia Vita® Women’s Probiotic® contains a proprietary blend of beneficial bacteria strains that support optimal gut function, hormonal balance, and immune system support. These carefully selected probiotic strains work in harmony to promote a balanced gut microbiome, helping women feel their best from the inside out.
“We are excited to introduce Mia Vita® Women’s Probiotic supplement as the latest addition to our line of women’s wellness products,” said Gerianne DiPiano, CEO and founder, FemmePharma. “At FemmePharma, we understand that women’s health needs are ever-evolving so we’re empowering women to take charge of their health journey, providing them with a powerful tool to navigate the challenges associated with perimenopause and menopause. This supplement embodies our mission to create tailored solutions that resonate with the unique needs of women.”
Mia Vita® Women’s Probiotic is now available for purchase exclusively on the FemmePharma website Customers and healthcare professionals can learn more about the product’s benefits, ingredients, and usage guidelines on the website.
For media inquiries, please contact Meaghan F. Washington at [email protected] or 215-370-5302.
About FemmePharma
FemmePharma is a pioneering brand dedicated to creating science-backed women’s wellness products that empower women to take control of their health. With a focus on addressing the unique needs and challenges faced by women experiencing symptoms of perimenopause, menopause and postmenopause, FemmePharma develops innovative solutions that promote vitality, balance, and well-being.
Media Contact
Meaghan F. Washington, Francis Goodwin PR LLC, 1 2153705302, hello@francisgoodwinpr.com
SOURCE FemmePharma
Sports Research Introduces First-to-Market Organic Collagen Peptides
LOS ANGELES, Sept. 14, 2023 /PRNewswire-PRWeb/ — Sports Research, the premier family-owned and operated company for vitamins, supplements, and performance essentials, proudly announces the groundbreaking launch of the first Organic Collagen Peptides. As the next step following years of dedication to innovation, Sports Research has partnered with a pioneer in collagen bio-extraction to transform nutritional supplements and reshape the future of wellness with this unique, organic collagen product.
While collagen is the most abundant protein in the human body, the aging process causes our bodies to produce less of it over time. The benefits of consuming collagen peptides have been valued for their potential to improve hair, skin, nails, joints and workout recovery support. However, the quest for an organic collagen option has yielded limited results due to processing challenges, until now. Sports Research has partnered with the best in the industry to bring to market an innovative methodology that eliminates the tedious gelatin stage inherent to previous collagen production processes, resulting in collagen with new levels of purity and collagen protein content never before seen on the market.
“At Sports Research, we are dedicated to creating products that empower every individual customer along their unique wellness journey. The introduction of the first Organic Collagen Peptides is a monumental step in furthering this commitment,” stated Mike Pedersen, COO at Sports Research. “Ever since the successful introduction of our first Collagen Peptides in 2015, we have always strived to deliver an organic option, and after years of development, we are proud to offer a much-needed organic collagen solution.”
Sports Research’s Organic Collagen Peptides are crafted using sustainable technology and traceable ingredients. A testament to the company’s commitment to environmental responsibility — the production process used for organic collagen adheres to the highest sustainability standards, resulting in an impressive 70% reduction in water use and 66% less energy consumption. The promise of a gluten-free, non-GMO product free from harsh chemicals, coupled with Informed Choice testing for banned and contaminated substances, cements this first-to-market collagen as a quality champion.
Organic Collagen Peptides Powder seamlessly integrates into consumers’ culinary creations, and blends effortlessly into beverages like hot coffee and smoothies without altering the product’s essence. Each scoop delivers 10 grams of low molecular weight collagen containing 18 amino acids, including 8 essential ones required for the healthy synthesis of protein, to foster vitality and aid in workout recovery. A true companion in the wellness journey, Sports Research’s Organic Collagen Peptides reach the highest industry standards, in terms of quality, transparency and environmental impact.
Sports Research Organic Collagen Peptides are now available for purchase on www.sportsresearch.com for $35.95.
About Sports Research
Since 1980, Sports Research has been a family-owned and operated company founded on a passion for fitness, wellness, and healing. Our flagship product, Sweet Sweat, quickly gained popularity and paved the way for a wide range of proven, research-backed health and fitness products designed for everybody — inside and out. At Sports Research, we are committed to using only the highest quality ingredients and materials sourced from around the world, many of which have been the center of scientific studies, just like our name implies. Our team of experts is dedicated to helping people live their best lives by providing innovative and effective health and fitness solutions. To learn more about our commitment to quality and our range of products, visit our new websites: sportsresearch.com and sweetsweat.com.
Media Contact
Sports Research, Trust Relations, 1 6109051817, [email protected]
SOURCE Sports Research
Most recently, Pussinen served as Chief Technical Officer for Spark Therapeutics, Inc., a fully integrated, commercial gene therapy company, and a member of the Roche Group. Prior to joining Spark in 2021, Pussinen’s leadership roles included six years with Ipsen Biomeasure and Ipsen Biosciences, U.S. R&D-focused subsidiaries of Ipsen, where she served as President and CEO. Pussinen previously served as Executive Vice President, Technical Development, Operations and Supply Chain for Actinium Pharmaceuticals, Inc. and as Global Vice President and General Manager, Life Sciences and Specialty Chemicals for Honeywell International.
“Cynthia Pussinen is an extremely accomplished and respected scientist and global pharmaceutical executive with an impressive track record of bringing innovative new products to market in various leadership roles at several highly acclaimed life sciences companies,” said Leslie Loveless, Slone Partners CEO. “She will make for a terrific addition to the Sernova leadership team and Board of Directors during a pivitol stage in the company’s evolution.”
“Sernova has demonstrated tremendous growth over the past several years as it has transitioned from a research company to one that is moving towards commercialization of a product for the treatment of multiple chronic diseases. As a united Board, we feel now is the time to bring in an industry leader with extensive experience with large pharmaceutical companies as well as entrepreneurial biotech and advanced therapeutics focused companies,” commented Brett Whalen, Chair of the Board of Directors of Sernova. “The skills that Ms. Pussinen brings to our company include over 25 years of global experience shepherding new therapies from development through commercialization across multiple conditions with sales measured in the billions.”
Pussinen earned a Master of Science in R&D management from Rensselaer Polytechnic Institute and a Bachelor of Science in chemistry, with a minor in engineering from the University of Connecticut.
ABOUT SLONE PARTNERS
Founded in 2000, Slone Partners is the premier executive search firm that delivers top diverse and visionary leaders who build amazing life sciences, healthcare, and cybersecurity organizations. With a nationwide presence in the most active industry hubs, we specialize in discovering and placing world-class C-Suite leadership, executive, and upper management talent with experience, conviction, and cultural competence in emerging and well-established companies. Our portfolio of executive search and advisory services includes diversity, equity, and inclusion strategy, education, and training. Slone Partners proudly holds the designation as a Certified LGBT Business Enterprise™ by the National Gay & Lesbian Chamber of Commerce (NGLCC) and has earned recognition as a Top Executive Search Firm and a Top 20 Diversity and Inclusion Services firm by Manage HR. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.
ABOUT SERNOVA CORPORATION
Sernova Corporation is a clinical-stage biotechnology company that is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. Sernova is currently focused on developing a ‘functional cure’ for insulin-dependent diabetes with its lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. On implantation, The Cell Pouch forms a natural vascularized tissue environment in the body for long-term survival and function of therapeutic cells that release essential factors that are absent or deficient in the bodies of patients with certain chronic diseases. Sernova’s Cell Pouch System has demonstrated its potential to be a ‘functional cure’ for people with T1D in an ongoing Phase 1/2 clinical study at the University of Chicago. Sernova is also advancing a proprietary technology in collaboration with the University of Miami to shield therapeutic cells from immune system attack with the goal to eliminate the need for chronic, systemic immunosuppression. For more information, visit the website: https://sernova.com/.
Media Contact
Doug Gavel, Doug Gavel Communications, (617) 429-4417, [email protected], www.douggavel.com
SOURCE Slone Partners
LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 75,000 units (the “Units”), with each Unit consisting of one share of…
Una nueva sede contará con más de 1,000 empleados, todos los cuales trabajarán para crear un sistema de salud digno de nuestra familia y amigos, además de sosteniblemente económico LONG BEACH, Calif., 13 de septiembre de 2023 /PRNewswire-HISPANIC PR WIRE/ — Blue Shield of California y…
OVERLAND PARK, Kan., Sept. 13, 2023 /PRNewswire/ — Concorde Career Colleges National Dean of Nursing Marlo D. Robinson, DNP, JD, RN, will be a speaker at the International Society for Professional Identity in Nursing (ISPIN) 2023 Symposium. This symposium will be held Sept. 18 through…
